Wish Recovery’s Blog Monthly Archives

You typed something into a search bar tonight that you've been thinking about for weeks. Maybe months. Something about GLP-1, alcohol, and whether the stories about Ozempic and drinking are pointing toward something real. We've been watching this research too, and we want to share what we've learned.

Key Takeaways

• New 2026 research shows semaglutide can reduce alcohol cravings and heavy drinking days.
• GLP-1 medications work on the brain's reward system, where the pull toward drinking lives.
• Semaglutide isn't FDA-approved for alcohol use disorder—it's used off-label with medical supervision.
• Medication alone doesn't replace therapy, dual-diagnosis care, or the structure of residential treatment.

You don't have to figure out whether this applies to you alone. Reach out to our team at Wish and start a private, no-pressure conversation. Talk to Someone at Wish